Advancing Psychedelic Based Neurological Solutions

Akome is a researcher and developer of psychedelic-based pharmaceuticals for the purpose of addressing of neurological and mental health disorders with an initial focus on targeting treatments for Alzheimer’s Disease (Alzheimer’s), Parkinson’s Disease (Parkinson’s), Ischemic Stroke (Stroke), and Depression.

Sign up to our newsletter and stay up to date

By submitting your information, you are granting us permission to email you. You may unsubscribe at any time.

Akome Biotech Ltd.
+1 604-691-7485

3123 – 595 Burrard Street
Vancouver, BC V7X 1J1